U.S. alleges that Vitas Hospice and owner Chemed Corporation that “Vitas focused on maximizing Medicare reimbursement for as many patients as possible while disregarding patients’ medical needs and Medicare guidelines. Vitas regularly ignored concems expressed by its own physicians and nurses regarding whether its hospice patients were receiving appropriate care.”